Insider Transactions in Q4 2021 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2021
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
90,104
+13.57%
|
-
|
|
Nov 21
2021
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
90,104
-3.52%
|
-
|
|
Nov 02
2021
|
Lisa Deschamps Director |
SELL
Open market or private sale
|
Direct |
11,672
-12.46%
|
$0
$0.66 P/Share
|
|
Nov 02
2021
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,416
-0.07%
|
$0
$0.65 P/Share
|
|
Nov 02
2021
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
52,056
-0.31%
|
$0
$0.64 P/Share
|
|
Nov 01
2021
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
454,848
-2.76%
|
$0
$0.64 P/Share
|
|
Nov 01
2021
|
Claire Poll General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
79,896
-3.84%
|
$0
$0.64 P/Share
|
|
Nov 01
2021
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
454,848
-2.62%
|
$0
$0.64 P/Share
|
|
Nov 01
2021
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56,928
-2.0%
|
$0
$0.64 P/Share
|